The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance: A Meta-analysis
Open accessAbstract
Context: Ephedra and ephedrine sometimes are used for weight loss or enhanced athletic performance, but the efficacy and safety of these compounds are uncertain. Objective: To assess the efficacy and safety of ephedra and ephedrine used for weight loss and enhanced athletic performance. Data Sources: We searched 9 databases using the terms ephedra , ephedrine , adverse effect , side effect , efficacy , effective , and toxic . We included unpublished trials and non–English-language documents. Adverse events reported to the US Food and Drug Administration MedWatch program were assessed. Study Selection: Eligible studies were controlled trials of ephedra or ephedrine used for weight loss or athletic performance and case reports of adverse events associated with such use. Eligible studies for weight loss were human studies with at least 8 weeks of follow-up; and for athletic performance, those having no minimum follow-up. Eligible case reports documented that ephedra or ephedrine was consumed within 24 hours prior to an adverse event or that ephedrine or an associated product was found in blood or urine, and that other potential causes had been excluded. Of the 530 articles screened, 52 controlled trials and 65 case reports were included in the adverse events analysis. Of more than 18 000 other case reports screened, 284 underwent detailed review. Data Extraction: Two reviewers independently identified trials of efficacy and safety of ephedra and ephedrine on weight loss or athletic performance; disagreements were resolved by consensus. Case reports were reviewed with explicit and implicit methods. Data Synthesis: No weight loss trials assessed duration of treatment greater than 6 months. Pooled results for trials comparing placebo with ephedrine (n = 5), ephedrine and caffeine (n = 12), ephedra (n = 1), and ephedra and herbs containing caffeine (n = 4) yielded estimates of weight loss (more than placebo) of 0.6 (95% confidence interval, 0.2-1.0), 1.0 (0.7-1.3), 0.8 (0.4-1.2), and 1.0 (0.6-1.3) kg/mo, respectively. Sensitivity analyses did not substantially alter the latter 3 results. No trials of ephedra and athletic performance were found; 7 trials of ephedrine were too heterogeneous to synthesize. Safety data from 50 trials yielded estimates of 2.2- to 3.6-fold increases in odds of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations. Data are insufficient to draw conclusions about adverse events occurring at a rate less than 1.0 per thousand. The majority of case reports are insufficiently documented to allow meaningful assessment. Conclusions: Ephedrine and ephedra promote modest short-term weight loss (≈0.9 kg/mo more than placebo) in clinical trials. There are no data regarding long-term weight loss, and evidence to support use of ephedra for athletic performance is insufficient. Use of ephedra or ephedrine and caffeine is associated with increased risk of psychiatric, autonomic, or gastrointestinal symptoms, and heart palpitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, ephedrine is associated with increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms 134, which likely will preclude the use of ephedrine itself for the treatment of obesity.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
In the citing paper
“A meta-analysis of several dozen trials showed that ephedrine promotes modest short-term weight loss, but there are no data on longer-term efficacy 134.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
In the citing paper
“Unfortunately, ephedrine is associated with increased risk of psychiatric, autonomic, gastrointestinal, and cardiovascular symptoms 134, which likely will preclude the use of ephedrine itself for the treatment of obesity.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F. C., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 896
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 8×
“Molnar et al,27 2000 4 Ephedrine (30-60) and caffeine (100 for 1 wk) 20 wk 16 16 0.”
InfluentialLong-term Weight Loss With Sibutramine
Wirth, A. G., & Krause, J. (2001) · JAMA · doi:10.1001/jama.286.11.1331 · Cited by 267
Research works printed but not linked: 13
- Abrahamson, 2001, Wheeler used supplement., Los Angeles Times
- Carey, 2001, Risks of ephedra usage in spotlight., Los Angeles Times
- Marsa, 2002, A tug of war in a larger battle: ephedra is now under intense scrutiny., Los Angeles Times
- Moheb, 1998, Effect of ephedrine, caffeine, and aspirin, in combinations of weight loss in obese women [abstract]., Int J Obes Relat Metab Disord, 22, S264
- Colker, 2001, A pilot study evaluating the effects of an ephedrine and forskolin-based product on body weight and body composition in overweight, healthy women [abstract]., J Am Coll Nutr, 20, 98
- Jensen, 1980, Elsinore tablets and ephedrine as slimming agents [in Danish]., Ugeskr Laeger, 142, 1499
- Kettle, 1998, Ephedrine/caffeine enhances abdominal fat loss in females., Int J Obes Relat Metab Disord, 22, S264
- Lumholtz, 1980, Ephedrine in the treatment of obesity [in Danish]., Ugeskr Laeger, 142, 1487
- Quaade, 1992, The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet [in Danish]., Ugeskr Laeger, 154, 1258
- Roed, 1980, Elsinore banting tablets [in Danish]., Ugeskr Laeger, 142, 1491
- Breum, 1994, Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity., Int J Obes Relat Metab Disord, 18, 99
- Not Available, 2001, >Stata [computer program].
- Not Available, 2000, StatXact 4 [computer program].
Cited by
Sorted by citations
Items 101–200 of 511
Seizures Reported in Association with Use of Dietary Supplements
HALLER, C. A., Meier, K. H., & Olson, K. R. (2005) · Clinical Toxicology · doi:10.1081/clt-200044771 · Cited by 57
Kim, H.-J., Park, J.-M., Kim, J.-A., & Ko, B.-P. (2008) · Journal of Acupuncture and Meridian Studies · doi:10.1016/s2005-2901(09)60033-9 · Cited by 57
Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician
Angell, P. J., Chester, N. J., Sculthorpe, N. F., Whyte, G., George, K., & Somauroo, J. D. (2012) · British Journal of Sports Medicine · doi:10.1136/bjsports-2012-091186 · Cited by 59
Phinney, K. W., Ihara, T., & Sander, L. C. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.04.068 · Cited by 56
Herbal Remedies in Gastroenterology
Comar, K. M., & Kirby, D. F. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000165650.09500.3a · Cited by 57
Marchei, E., Pellegrini, M., Pacifici, R., Zuccaro, P., & Pichini, S. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.02.043 · Cited by 55
Hou, J., Zheng, J., Rizvi, S. A. A., & Shamsi, S. A. (2007) · Electrophoresis · doi:10.1002/elps.200600415 · Cited by 54
Brito, A. D. F., de Oliveira, C. V. C., Brasileiro-Santos, M. D. S., & Santos, A. D. C. (2013) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12074 · Cited by 54
Vukovich, M. D., Schoorman, R., Heilman, C. J., Jacob, P., & Benowitz, N. L. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04152.x · Cited by 53
Belza, A., & Jessen, A. B. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602121 · Cited by 52
Hallas, J., Bjerrum, L., Støvring, H., & Andersen, M. T. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn191 · Cited by 51
Herbal Drugs of Abuse: An Emerging Problem
Richardson, W. H., Slone, C. M., & Michels, J. E. (2007) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2007.02.009 · Cited by 50
Modelling the cardiovascular effects of ephedrine
Persky, A. M., Berry, N. S., Pollack, G. M., & Brouwer, K. L. R. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02062.x · Cited by 50
Hepatic Damage by Natural Remedies
Medina-Caliz, I., Gonzalez-Jimenez, A., Garcia-Cortes, M., Lucena, M. I., & Andrade, R. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1623518 · Cited by 40
Nutraceutical Supplements for Weight Loss
Poddar, K. H., Kolge, S., Bezman, L., Mullin, G. E., & Cheskin, L. J. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611419859 · Cited by 49
Palamar, J. J. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.07.007 · Cited by 49
Petróczi, A., & Naughton, D. P. (2007) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-2-4 · Cited by 55
Dietary Supplements for Improving Body Composition and Reducing Body Weight: Where Is the Evidence?
Manore, M. M. (2012) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.22.2.139 · Cited by 48
Pepe, R. B., Lottenberg, A. M., Fujiwara, C. T. H., Beyruti, M., Cintra, D. E., Machado, R. M., Rodrigues, A., Jensen, N. S. O., Caldas, A. P. S., Fernandes, A. E., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01037-6 · Cited by 59
Complementary and Alternative Medicine and the Management of the Metabolic Syndrome
Hollander, J. M., & Mechanick, J. I. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.12.007 · Cited by 45
Dietary supplement-related adverse events reported to the California Poison Control System
Dennehy, C. E., Tsourounis, C., & Horn, A. J. (2005) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp040412 · Cited by 45
Maglione, M., Miotto, K. A., Iguchi, M. Y., Jungvig, L., Morton, S. C., & Shekelle, P. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.189 · Cited by 45
Self-citationThyrotoxicosis Caused by Weight-Reducing Herbal Medicines
Ohye, H., Fukata, S., Kanoh, M., Kubota, S., Kuma, K., Miyauchi, A., & Sugawara, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.831 · Cited by 43
Overweight and Obesity in Adults
Mackerras, D. (2004) · Cited by 43
Eng, Y. S., Lee, C., Lee, W. C., Huang, C. C., & Chang, J. (2019) · Molecules · doi:10.3390/molecules24193505 · Cited by 43
Durazzo, A., Sorkin, B. C., Lucarini, M., Gusev, P. A., Kuszak, A. J., Crawford, C. C., Boyd, C. C., Deuster, P. A., Saldanha, L. G., Gurley, B. J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.714434 · Cited by 42
Herbals Used for Diabetes, Obesity, and Metabolic Syndrome
Najm, W. I., & Lie, D. (2010) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2010.02.008 · Cited by 45
Song, M.-K., Um, J., Jang, H.-J., & Lee, B.-C. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.462 · Cited by 40
Sale, C., Harris, R. C., Delves, S. K., & Corbett, J. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803209 · Cited by 41
Chamorro, M. F., & Ladio, A. H. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02952-1 · Cited by 41
Food Supplements for Body Weight Reduction: A Systematic Review of Systematic Reviews
Onakpoya, I., Wider, B., Pittler, M. H., & Ernst, E. (2010) · Obesity · doi:10.1038/oby.2010.185 · Cited by 41
Drugs Alias Dietary Supplements
DeAngelis, C. D. (2003) · JAMA · doi:10.1001/jama.290.11.1519 · Cited by 41
Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity
Rogovik, A. L., Chanoine, J., & Goldman, R. D. (2010) · Drugs · doi:10.2165/11319210-000000000-00000 · Cited by 40
Marchei, E., Pichini, S., Pacifici, R., Pellegrini, M., & Zuccaro, P. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.03.035 · Cited by 40
Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products
Bersani, F. S., Coviello, M., Imperatori, C., Francesconi, M., Hough, C. M., Valeriani, G., Stefano, G. D., Posocco, F. B. M., Santacroce, R., Minichino, A., et al. (2015) · BioMed Research International · doi:10.1155/2015/120679 · Cited by 40
Drugs in the Pipeline for the Obesity Market
Klonoff, D. C., & Greenway, F. L. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200525 · Cited by 38
Liu, A. G., Smith, S. R., Fujioka, K., & Greenway, F. L. (2013) · Obesity · doi:10.1002/oby.20416 · Cited by 39
Soup or Art? The role of evidential force in empirical software engineering
Pfleeger, S. L. (2005) · IEEE Software · doi:10.1109/ms.2005.19 · Cited by 39
Developing and Implementing Core Competencies for Integrative Medicine Fellowships
Ring, M. R., Brodsky, M., Dog, T. L., Sierpina, V. S., Bailey, M. L., Locke, A., Kogan, M., Rindfleisch, J. A., & Saper, R. B. (2014) · Academic Medicine · doi:10.1097/acm.0000000000000148 · Cited by 38
Physiological effects following administration of Citrus aurantium for 28 days in rats
Hansen, D. K., George, N. I., White, G. E., Pellicore, L. S., Abdel-Rahman, A., & Fabricant, D. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.006 · Cited by 38
Ephedrine treatment for autoimmune myasthenia gravis
Lipka, A. F., Vrinten, C., van Zwet, E. W., Schimmel, K. J. M., Cornel, M. C., Kuijpers, M. R., Hekster, Y. A., Weinreich, S. S., & Verschuuren, J. J. G. M. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.11.009 · Cited by 38
Dietary Herbal Supplements with Phenylephrine for Weight Loss
Greenway, F. L., de Jonge, L., Martin, C. K., Roberts, A. T., Grundy, I., & Parker, C. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.572 · Cited by 38
Doping and musculoskeletal system: short‐term and long‐lasting effects of doping agents
Nikolopoulos, D., Spiliopoulou, C., & Theocharis, S. E. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00881.x · Cited by 41
Ray, S. D., Patel, N., Shah, N. C., Nagori, A., Naqvi, A., & STOHS, S. J. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9235-2 · Cited by 37
Cardiovascular Toxicity of Citrus aurantium in Exercised Rats
Hansen, D. K., George, N. I., White, G. E., Abdel-Rahman, A., Pellicore, L. S., & Fabricant, D. (2013) · Cardiovascular Toxicology · doi:10.1007/s12012-013-9199-x · Cited by 37
Wang, J., Kim, B. S., Han, K., & Kim, H. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14060555 · Cited by 36
Combinations of drugs in the Treatment of Obesity
Halpern, B., Oliveira, E. S. L., Faria, A. M., Halpern, A., de Melo, M. E., Cercato, C., & Mancini, M. C. (2010) · Pharmaceuticals · doi:10.3390/ph3082398 · Cited by 36
Electrical Stimulation as Treatment for Obesity and Diabetes
Greenway, F. L., & Zheng, J. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100216 · Cited by 36
Kuszak, A. J., Hopp, D. C., Williamson, J. S., Betz, J. M., & Sorkin, B. C. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1931 · Cited by 37
Ephedra-Containing Dietary Supplements in the US versus Ephedra as a Chinese Medicine
Mehendale, S. R., Bauer, B. A., & Yuan, C.-S. (2004) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x04001680 · Cited by 36
Complementary and Alternative Medicine
Tokumoto, J., & Abrams, D. I. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50051-4 · Cited by 35
Zheng, M., Zhou, H., Wan, H., Chen, Y., & He, Y. T. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.043 · Cited by 35
Qiu, P., Chen, X., Chen, X., LIN, L., & AI, C. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.09.034 · Cited by 34
Lee, H., Kang, R., & Yoon, Y. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.12.002 · Cited by 34
Hepatic injury due to drugs, herbal compounds, chemicals and toxins
Lewis, J. H., & Kleiner, D. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00013-1 · Cited by 34
Risk Associated with the Use of Selected Ingredients in Food Supplements
Jędrejko, K., Lazur, J., & Muszyńska, B. (2021) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000686 · Cited by 32
Xia, Y., Kuang, H., Yang, B.-Y., Wang, Q., Liang, J., Sun, Y., & Wang, Y. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.11.035 · Cited by 31
Dietary Supplements Use in Competitive and Non-Competitive Boxer: An Exploratory Study
Mazzeo, F., & Santamaria, S. (2016) · Biology and Medicine · doi:10.4172/0974-8369.1000294 · Cited by 32
Roy, S., Shah, H. A., Rink, C. L., Khanna, S., Bagchi, D., Bagchi, M., & Sen, C. K. (2007) · DNA and Cell Biology · doi:10.1089/dna.2007.0617 · Cited by 31
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects
Csajka, C., HALLER, C. A., Benowitz, N. L., & Verotta, D. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02254.x · Cited by 31
Physiological process of fat loss
El-Zayat, S. R., Sibaii, H., & El-Shamy, K. A. (2019) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-019-0238-z · Cited by 40
Ephedrine and Other Stimulants As Ergogenic Aids
Bohn, A. M., Khodaee, M., & Schwenk, T. L. (2003) · Current Sports Medicine Reports · doi:10.1249/00149619-200308000-00009 · Cited by 30
Brown and beige adipose tissue: New therapeutic targets for metabolic disorders
Magro, B. S., & Dias, D. P. M. (2024) · Health Sciences Review · doi:10.1016/j.hsr.2024.100148 · Cited by 34
Park, J.-H., Lee, M.-J., Song, M., Bose, S., Shin, B., & Kim, H. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2011.1982 · Cited by 29
Current pharmacotherapeutic concepts for the treatment of obesity in adults
Idelevich, E. A., Kirch, W., & Schindler, C. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708098226 · Cited by 29
Al‐Shuhaib, M. B. S., & Al‐Shuhaib, J. M. B. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401754 · Cited by 29
Safety Issues Associated with Herbal Ingredients
Elvin-Lewis, M. P. F. (2005) · Advances in food and nutrition research · doi:10.1016/s1043-4526(05)50007-x · Cited by 28
Complementary and Alternative Therapies for Weight Loss
Steyer, T. E., & Ables, A. Z. (2009) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2009.01.011 · Cited by 28
Osuna‐Prieto, F. J., Martínez‐Téllez, B., Sánchez‐Delgado, G., Aguilera, C. M., Lozano‐Sánchez, J., Arraéz-Román, D., Segura‐Carretero, A., & Ruiz, J. R. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy067 · Cited by 26
Wu, C., Cheng, W., Xing, H., Dang, Y., Li, F., & Zhu, Z. (2011) · BioMed Research International · doi:10.1155/2011/159834 · Cited by 26
The ABC Clinical Guide to Herbs
Halsted, C. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.1127 · Cited by 27
Epidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26
Yoo, H.-J., Yoon, H.-Y., Yee, J., & Gwak, H. S. (2021) · Pharmaceuticals · doi:10.3390/ph14111198 · Cited by 26
Scientific Opinion on safety evaluation of Ephedra species for use in food
(ANS), E. P. O. F. A. A. N. S. A. T. F. (2013) · EFSA Journal · doi:10.2903/j.efsa.2013.3467 · Cited by 26
Bitsko, R. H., Reefhuis, J., Louik, C., Werler, M. M., Feldkamp, M. L., Waller, D. K., Frías, J. L., & Honein, M. A. (2008) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20472 · Cited by 26
Medico-legal perspectives on sudden cardiac death in young athletes
Oliva, A., Grassi, V. M., Campuzano, Ó., Brión, M., Arena, V., Partemi, S., Coll, M., Pascali, V. L., Brugada, J., Carracedo, Á., et al. (2016) · International Journal of Legal Medicine · doi:10.1007/s00414-016-1452-y · Cited by 25
Metabolic Implications of Obesity: Before and After Gastric Bypass
Richardson, D. W., & Vinik, A. I. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.12.009 · Cited by 26
Medical Therapy for Obesity—Current Status and Future Hopes
Bray, G. A. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.013 · Cited by 26
Dodge, T. L. (2015) · Drug Testing and Analysis · doi:10.1002/dta.1857 · Cited by 27
Are non-prescription medications needed for weight control?
Bray, G. A. (2008) · Obesity · doi:10.1038/oby.2007.100 · Cited by 25
Protecting military personnel from high risk dietary supplements
Deuster, P. A., & Lieberman, H. R. (2015) · Drug Testing and Analysis · doi:10.1002/dta.1866 · Cited by 25
Translational Pharmacology and Physiology of Brown Adipose Tissue in Human Disease and Treatment
Larson, C. J. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_184 · Cited by 26
Yang, H. J., Lee, Y. H., Lee, S. R., Kaya, P., Hong, E., & Lee, H. W. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112300 · Cited by 25
Khaw, K. S., Kee, W. D. N., & Lee, S. W. Y. (2006) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539506001756 · Cited by 25
Li, M., Liu, Y., Li, H., Qi, Y., & Lu, F. L. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1963 · Cited by 25
Biologically Active Compounds in Food Products and Their Effects on Obesity and Diabetes
Witkamp, R. F. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00063-0 · Cited by 27
Knapik, J. J., Trone, D. W., Steelman, R. A., Farina, E. K., & Lieberman, H. R. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112840 · Cited by 25
Unhealthy Weight Control Practices: Culprits and Clinical Recommendations
Ferraro, Z. M., Patterson, S., & Chaput, J. (2015) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s23060 · Cited by 28
Consumption of Green Tea Extract Results in Osteopenia in Growing Male Mice , ,
Iwaniec, U. T., Turner, R. T., Koo, S. I., Kaur, R., Ho, E., Wong, C. P., & Bruno, R. S. (2009) · Journal of Nutrition · doi:10.3945/jn.109.107201 · Cited by 24
Effect of extractions from Ephedra sinica Stapf on hyperlipidemia in mice
Fan, Y., Li, J., Yin, Q., Zhang, Y., Xu, H., SHI, X., LI, C., Zhou, Y., & ZHOU, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.2117 · Cited by 24
Medications for Weight Reduction
Bray, G. A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.08.004 · Cited by 24
Seamon, M. J., & Clauson, K. A. (2005) · Journal of Herbal Pharmacotherapy · doi:10.1080/j157v05n03_07 · Cited by 24
Is there an association between ephedra and heart failure? a case series
Peters, C. M., O’Neill, J., Young, J. B., & Bott‐Silverman, C. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.04.003 · Cited by 24
Patterns of Ephedra and Other Stimulant Use in Collegiate Hockey Athletes
Bents, R. T., & Marsh, E. E. (2006) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.16.6.636 · Cited by 24
Kleiner, D. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00012-1 · Cited by 24
Acute Myocardial Infarction Induced by Ephedrine Alkaloids
Enders, J. M., Dobesh, P. P., & Ellison, J. N. (2003) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.15.1645.31959 · Cited by 23
YAMADA, I., Goto, T., Takeuchi, S., Ohshima, S., Yoneyama, K., Shibuya, T., Kataoka, E., Segawa, D., Sato, W., Dohmen, T., et al. (2008) · Cytokine · doi:10.1016/j.cyto.2007.12.003 · Cited by 23
Ephedrine, Pseudoephedrine, and Amphetamine Prevalence in College Hockey Players
Bents, R. T., Tokish, J. M., & Goldberg, L. (2004) · The Physician and Sportsmedicine · doi:10.1080/00913847.2004.11440733 · Cited by 23
Safety Assurances for Dietary Supplements
Basch, E., Servoss, J. C., & Tedrow, U. B. (2005) · Journal of Herbal Pharmacotherapy · doi:10.1080/j157v05n01_02 · Cited by 23
Water Consumption: Effect on Energy Expenditure and Body Weight Management
Dazıroğlu, M. E. Ç., & Tek, N. A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00501-8 · Cited by 28
Metadata
- Authors
- Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J.
- Affiliations
- RAND Corporation (US)
- Cedars-Sinai Medical Center (US)
- University of Southern California (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-03-26
- Volume
- 289
- Issue
- 12
- Pages
- 1537
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1999289755
- Cited by
- 511
- References
- 43
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 9 · 2019: 15 · 2018: 16 · 2017: 16 · 2016: 19 · 2015: 21 · 2014: 20 · 2013: 17 · 2012: 23
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Health Services Research and Development
- U.S. Public Health Service (290-97-0001)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Social Sciences › Sociology and Political Science › Doping in Sports
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
- Keywords
- Ephedra, ephedrine, weight loss, athletic performance, stimulants, caffeine, adverse events, drug safety, efficacy, herbal supplements, performance-enhancing drugs
- MeSH terms
- Caffeine, Ephedrine, Humans, Physical Endurance, Risk, Sports, Weight Loss, Randomized Controlled Trials as Topic, Controlled Clinical Trials as Topic, Anti-Obesity Agents, Dietary Supplements, Plant Preparations, Ephedra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
